Convulsant action of systemically administered glutamate and bicuculline methiodide in immature rats

Epilepsy Research

Volumn 42, Issue 2-3, 2000, Pages 183-189

  Mareš, Pavel ^a   Chino, Michal ^a   Kubová, Hana ^a   Mathern, Peter ^a   Veliký, Miroslav ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Bicuculline methiodide; Blood brain barrier; Glutamate; Ontogenesis; Rats; Seizures

Indexed keywords

CONVULSANT AGENT; GLUTAMIC ACID;

ANIMAL MODEL; ARTICLE; AUTOMATISM; BLOOD BRAIN BARRIER; CLONIC SEIZURE; EPILEPTOGENESIS; GRAND MAL SEIZURE; IMMATURITY; NONHUMAN; PRIORITY JOURNAL; RAT; TONIC CLONIC SEIZURE;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BICUCULLINE; CONVULSANTS; GLUTAMIC ACID; MALE; RATS; RATS, WISTAR; SEIZURES;

EID: 0033763851     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(00)00179-0     Document Type: Article

References (34)

1. The entry of acidic amino acids into brain and CSF during development using in situ perfusion in the rat
2. Acidic amino acid accumulation by rat choroid plexus during development
3. Changes in the kinetics of the acidic amino acid brain and CSF uptake during development in the rat
4. Monosodium glutamate induces convulsive disorders in rats
5. Bicuculline and central GABA receptors
6. The development of the blood-brain barrier
7. Developmental changes in neuronal sensitivity to excitatory amino acids in area CA1 of the rat hippocampus
8. Anticonvulsant action of a NMDA receptor antagonist CGP 40116 varies only quantitatively during ontogeny in rats
9. Permeability and vascularity of the developing brain: Cerebellum versus cerebral cortex
10. Convulsions induced in 10-day-old rats by intraperitoneal injection of monosodium glutamate and related excitant amino acids
11. Current aspects of the development of the blood-brain barrier
12. Effects of NNC 711, a GABA uptake inhibitor, on pentylenetetrazol-induced seizures in developing and adult rats
13. Characterization of endothelial cell transport in the developing mouse blood-brain barrier
14. Convulsant action of D, L-homocysteic acid and its stereoisomers in immature rats
15. Motor and electrocorticographic epileptic activity induced by 3-mercaptopropionic acid in immature rats
16. N-methyl-D-aspartate (NMDA)-induced seizures in developing rats
17. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system
18. Development of physiological variables important for drug kinetics
19. Monosodium L-glutamate-induced convulsions: Temporary alteration in blood-brain barrier permeability to plasma proteins
20. N-methylbicuculline, a convulsant more potent than bicuculline
21. Bicuculline methiodide in the blood-brain barrier-epileptogen model of epilepsy
22. Development of human blood-CSF-brain barrier
23. Development of the blood-brain barrier
24. Transport of glutamate and other amino acids at the blood-brain barrier
25. New model of cortical epileptic foci in freely moving developing rats
26. Anticonvulsant effect of progabide in rats during ontogenesis
27. Electroencephalographic study of L-glutamate induced seizures in rats
28. NMDA receptors in the visual cortex of young kittens are more effective than those of adult cats
29. Excitatory amino acid antagonists and pentylenetetrazole-induced seizures during ontogenesis: I. The effects of 2-amino-7-phosphonoheptanoate
30. Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis. IV. Effect of CGP 39551
31. Epileptic phenomena produced by kainic acid in laboratory rats during ontogenesis
32. Bicuculline-induced neocortical epileptiform foci and the effects of 6-hydroxydopamine in developing rats
33. Provocation of cerebral seizures by dearangement of the natural balance between glutamic acid and gamma-aminobutyric acid
34. Motor and electrocorticographic epileptic activity induced by bicuculline in developing rats